AU2001290317A1 - Novel peptides - Google Patents
Novel peptidesInfo
- Publication number
- AU2001290317A1 AU2001290317A1 AU2001290317A AU9031701A AU2001290317A1 AU 2001290317 A1 AU2001290317 A1 AU 2001290317A1 AU 2001290317 A AU2001290317 A AU 2001290317A AU 9031701 A AU9031701 A AU 9031701A AU 2001290317 A1 AU2001290317 A1 AU 2001290317A1
- Authority
- AU
- Australia
- Prior art keywords
- novel peptides
- peptides
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0033—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being non-polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000312600 | 2000-10-12 | ||
JP2000-312600 | 2000-10-12 | ||
PCT/JP2001/008565 WO2002030961A1 (en) | 2000-10-12 | 2001-09-28 | Novel peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001290317A1 true AU2001290317A1 (en) | 2002-04-22 |
Family
ID=18792161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001290317A Abandoned AU2001290317A1 (en) | 2000-10-12 | 2001-09-28 | Novel peptides |
Country Status (6)
Country | Link |
---|---|
US (1) | US20040171795A1 (en) |
EP (1) | EP1323731A4 (en) |
JP (1) | JPWO2002030961A1 (en) |
AU (1) | AU2001290317A1 (en) |
CA (1) | CA2425769A1 (en) |
WO (1) | WO2002030961A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011071155A1 (en) * | 2009-12-10 | 2011-06-16 | シスメックス株式会社 | Method for detection of basic peptide and reagent for detection of basic peptide |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0965597A4 (en) * | 1996-12-27 | 2003-01-08 | Mochida Pharm Co Ltd | Cell membrane-directed drugs |
-
2001
- 2001-09-28 WO PCT/JP2001/008565 patent/WO2002030961A1/en not_active Application Discontinuation
- 2001-09-28 CA CA002425769A patent/CA2425769A1/en not_active Abandoned
- 2001-09-28 US US10/398,933 patent/US20040171795A1/en not_active Abandoned
- 2001-09-28 EP EP01970293A patent/EP1323731A4/en not_active Withdrawn
- 2001-09-28 AU AU2001290317A patent/AU2001290317A1/en not_active Abandoned
- 2001-09-28 JP JP2002534346A patent/JPWO2002030961A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2425769A1 (en) | 2003-04-11 |
US20040171795A1 (en) | 2004-09-02 |
EP1323731A1 (en) | 2003-07-02 |
WO2002030961A1 (en) | 2002-04-18 |
EP1323731A4 (en) | 2005-02-09 |
JPWO2002030961A1 (en) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000267458A1 (en) | Hypercomputer | |
GB0014870D0 (en) | Peptides | |
AU2001220246A1 (en) | Neckphone | |
AU2001281965A1 (en) | Novel 6-phenylphenanthridines | |
AU2001284418A1 (en) | Novel polypeptide | |
AU2001240791A1 (en) | Sequence | |
AU2001262689A1 (en) | Oligopeptides | |
GB0029777D0 (en) | Peptides | |
AU2002211885A1 (en) | Antifungal peptides | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU2001244863A1 (en) | Apoptin-associating protein | |
GB0001825D0 (en) | Peptides | |
AU2001278975A1 (en) | Alpha-conotoxin peptides | |
AU2001274750A1 (en) | Novel beta-hydroxyamides | |
AU2002224056A1 (en) | Novel polypeptide | |
AU2001290317A1 (en) | Novel peptides | |
AU2001241044A1 (en) | Mitf-associated proteins | |
AU2001278777A1 (en) | Irap-binding protein | |
AUPQ591200A0 (en) | Novel peptides | |
GB0007263D0 (en) | Peptides | |
AU2001277614A1 (en) | Novel proteins | |
AU2001263032A1 (en) | Zsig33-like peptides | |
AU2001262806A1 (en) | Peptides | |
AU2002215753A1 (en) | Caml-binding peptides | |
AU2002328853A1 (en) | Carcinoma-related peptides |